Maria Rodriguez

14PUBLICATIONS

56CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (14)

Sort by Publication Date:

|Jul 02, 2026

Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma.

|Jun 24, 2026

A Patient-Derived Xenograft Repository Capturing Clinical and Molecular Heterogeneity of Large B-cell Lymphoma.

|Aug 07, 2025

Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial.

Paolo Strati, Lei Feng, Jason R Westin

|Jun 15, 2025

A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma.

Neha Akkad, Lei Feng, Jason R Westin

|Feb 05, 2025

Phase 2 trial of ibrutinib and nivolumab in patients with relapsed CNS lymphomas.

Dai Chihara, Raphael E Steiner, Ranjit Nair

|Jun 30, 2023

A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma.

Paolo Strati, Andrew Jallouk, Qing Deng

Pageof 3

Frequent Collaborators

13 joint publications

Jason Westin

12 joint publications

Sattva S Neelapu

Sairah Ahmed

Loretta Nastoupil

Dai Chihara

Francisco Vega

Christopher R Flowers

5 joint publications

Raphael Steiner

4 joint publications

Michael Wang

4 joint publications

Michael R Green

Frequent Collaborators

13 joint publications

Jason Westin

12 joint publications

Sattva S Neelapu

7 joint publications

Sairah Ahmed

5 joint publications

Loretta Nastoupil